ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Isis Pharmaceuticals's other long-term assets for the quarter that ended in Jun. 2014 was $5.3 Mil.
Isis Pharmaceuticals's quarterly other long-term assets declined from Dec. 2013 ($9.9 Mil) to Mar. 2014 ($9.5 Mil) and declined from Mar. 2014 ($9.5 Mil) to Jun. 2014 ($5.3 Mil).
Isis Pharmaceuticals's annual other long-term assets increased from Dec. 2011 ($11.9 Mil) to Dec. 2012 ($12.5 Mil) but then declined from Dec. 2012 ($12.5 Mil) to Dec. 2013 ($9.9 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Isis Pharmaceuticals Annual Data
|Other Long-Term Assets||9.2||8.8||4.3||7.6||5.3||17.8||15.8||11.9||12.5||9.9|
Isis Pharmaceuticals Quarterly Data
|Other Long-Term Assets||11.0||10.3||13.3||12.5||5.8||11.1||10.5||9.9||9.5||5.3|